In ovarian cancer, metronomic docetaxel chemotherapy in combination with AEE788, a combined EGFR and VEGFR inhibitor, has shown encouraging activity in an orthotopic mouse model utilising a cell line resistant to conventional chemotherapy dosing (Kamat et al, 2007). The gene discussed is EGFR; the disease is ovarian cancer.